[1] Kim JY, Kim HJ, Park JH, et al. Epidermal growth factor upregulates Skp2/Cks1 and p27(kip1) in human extrahepatic cholangiocarcinoma cells. World J Gastroenterol,2014,20:755-773. [2] Khattar V, Thottassery JV. Cks1: Structure, Emerging Roles and Implications in Multiple Cancers. J Cancer Ther, 2013,4:1341-1354. [3] Liu Z, Fu Q, Lv J, et al. Prognostic implication of p27Kip1, Skp2 and Cks1 expression in renal cell carcinoma: a tissue microarray study. J Exp Clin Cancer Res, 2008,27:51. [4] Lan Y, Zhang Y, Wang J, et al. Aberrant expression of Cks1 and Cks2 contributes to prostate tumorigenesis by promoting proliferation and inhibiting programmed cell death. Int J Cancer,2008,123:543-551. [5] Yang C, Nan H, Ma J, et al. High Skp2/Low p57(Kip2) expression is associated with poor prognosis in human breast carcinoma. Breast Cancer,2015,9:13-21. [6] Cui H, Zhao C, Gong P, et al. DNA methyltransferase 3A promotes cell proliferation by silencing CDK inhibitor p18INK4C in gastric carcinogenesis. Sci Rep,2015,5:13781. [7] Gutierrez-Escribano P, Nurse P. A single cyclin-CDK complex is sufficient for both mitotic and meiotic progression in fission yeast. Nat Commun,2015,6:6871. [8] Sha M, Ye J, Luan ZY, et al. Celastrol induces cell cycle arrest by MicroRNA-21-mTOR-mediated inhibition p27 protein degradation in gastric cancer. Cancer CellInt, 2015, 15:101. [9] Orlando S, Gallastegui E, Besson A, et al. p27Kip1 and p21Cip1 collaborate in the regulation of transcription by recruiting cyclin-Cdk complexes on the promoters of target genes. Nucleic Acids Res,2015,43:6860-6873. [10] Zhang Q, Hou D, Luo Z, et al. The novel protective role of P27 in MLN4924-treated gastric cancer cells. Cell Death Dis,2015,6:e1867. |